1. A79 CHARACTERISTICS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE AT DIAGNOSIS RELATED TO EARLIER USE OF BIOLOGIC THERAPY. (15th March 2019) Authors: Mulder, D J; Zachos, M; Issenman, R; Sherlock, M Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A103 PHENOTYPIC VARIATION IN PEDIATRIC IBD BY AGE: A MULTI-CENTRE INCEPTION COHORT STUDY OF THE CANADIAN CHILDREN IBD NETWORK. (1st March 2018) Authors: Dhaliwal, J; Church, P; Mack, D R; Huynh, H Q; Jacobson, K; EL-MATARY, W; deBruyn, J; Otley, A; Deslandres, C; Sherlock, M; Critch, J; Bax, K; Seidman, E G; Rashid, M; Jantchou, P; Issenman, R; Muise, A; Benchimol, E I; Wine, E; Carroll, M W Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A66 THE IMPACT OF A MULTIDISCIPLINARY ADOLESCENT AND YOUNG ADULT (AYA) INFLAMMATORY BOWEL DISEASE (IBD) ON CLINIC NO SHOW RATES. (21st February 2022) Authors: Sharma, R; Halder, S L; Zachos, M; Radoja, C; Grant, C; Chauhan, U; Brackenridge, E; Issenman, R; Sherlock, M; Dowhaniuk, J K; Pai, N; Brill, H; Ratcliffe, E; Narula, N; Marshall, J; Prowse, K Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗